For example, treatment of melanoma with the STING agonist ADU S-100 increased the production of several TLS-inducible factors, such as CCL19, CCL21, Lt-α, Lt-β, and Light, and inhibited melanoma growth [84]. This evidence concerns the gene LTA and melanoma.